{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:20:03Z","timestamp":1782152403349,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00117-020-00797-w","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T04:39:18Z","timestamp":1610512758000},"page":"150-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intensivierte Fr\u00fcherkennung mittels Magnetresonanztomographie in der Hochrisikosituation","High-risk screening using magnetic resonance imaging"],"prefix":"10.1007","volume":"61","author":[{"given":"Ulrich","family":"Bick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"797_CR1","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","volume":"381","author":"MF Bakker","year":"2019","unstructured":"Bakker\u00a0MF, de Lange\u00a0SV, Pijnappel\u00a0RM et\u00a0al (2019) Supplemental MRI screening for women with extremely dense breast tissue. N\u00a0Engl J Med 381:2091\u20132102","journal-title":"N Engl J Med"},{"key":"797_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s001170050258","volume":"37","author":"U Bick","year":"1997","unstructured":"Bick\u00a0U (1997) Integriertes Fr\u00fcherkennungskonzept bei Frauen mit genetischer Pr\u00e4disposition f\u00fcr Brustkrebs. Radiologe 37:591\u2013596","journal-title":"Radiologe"},{"key":"797_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10549-019-05152-9","volume":"175","author":"U Bick","year":"2019","unstructured":"Bick\u00a0U, Engel\u00a0C, Krug\u00a0B et al (2019) High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Res Treat 175:217\u2013228","journal-title":"Breast Cancer Res Treat"},{"key":"797_CR4","unstructured":"Deutsche Krebsgesellschaft (2020) Kennzahlenbogen FBREK. Anlage EB Version A1.1 vom 23.01.2020. https:\/\/www.onkozert.de\/wordpress\/wp-content\/uploads\/2020\/01\/eb_fbrek-A1-1_daten_200123.xlsx. Zugegriffen: 28. Okt. 2020"},{"key":"797_CR5","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1158\/1078-0432.CCR-18-0200","volume":"25","author":"RSC Guindalini","year":"2019","unstructured":"Guindalini\u00a0RSC, Zheng\u00a0Y, Abe\u00a0H et al (2019) Intensive surveillance with biannual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers. Clin Cancer Res 25:1786\u20131794","journal-title":"Clin Cancer Res"},{"key":"797_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","volume":"177","author":"BAM Heemskerk-Gerritsen","year":"2019","unstructured":"Heemskerk-Gerritsen\u00a0BAM, Jager\u00a0A, Koppert\u00a0LB et al (2019) Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 177:723\u2013733","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"797_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10549-020-05895-w","volume":"184","author":"N Hermann","year":"2020","unstructured":"Hermann\u00a0N, Klil-Drori\u00a0A, Angarita\u00a0FA et al (2020) Screening women at high risk for breast cancer: one program fits all? Subgroup analysis of a large population high risk breast screening program. Breast Cancer Res Treat 184(3):763\u2013770. https:\/\/doi.org\/10.1007\/s10549-020-05895-w","journal-title":"Breast Cancer Res Treat"},{"key":"797_CR8","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker\u00a0KB, Hopper\u00a0JL, Barnes\u00a0DR et\u00a0al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402\u20132416","journal-title":"JAMA"},{"key":"797_CR9","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1002\/cncr.25971","volume":"117","author":"HT Le-Petross","year":"2011","unstructured":"Le-Petross\u00a0HT, Whitman\u00a0GJ, Atchley\u00a0DP et al (2011) Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer. Cancer 117:3900\u20133907","journal-title":"Cancer"},{"key":"797_CR10","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00330-015-3807-z","volume":"25","author":"RM Mann","year":"2015","unstructured":"Mann\u00a0RM, Balleyguier\u00a0C, Baltzer\u00a0PA et\u00a0al (2015) Breast MRI: EUSOBI recommendations for women\u2019s information. Eur Radiol 25:3669\u20133678","journal-title":"Eur Radiol"},{"key":"797_CR11","first-page":"323","volume":"108","author":"A Meindl","year":"2011","unstructured":"Meindl\u00a0A, Ditsch\u00a0N, Kast\u00a0K et\u00a0al (2011) Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. Dtsch Arztebl Int 108:323\u2013330","journal-title":"Dtsch Arztebl Int"},{"key":"797_CR12","unstructured":"National Institute for Health and Care Excellence (2013) Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. https:\/\/www.nice.org.uk\/guidance\/cg164. Zugegriffen: 8. Jan. 2021"},{"key":"797_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jama.2019.8430","volume":"322","author":"HD Nelson","year":"2019","unstructured":"Nelson\u00a0HD, Pappas\u00a0M, Cantor\u00a0A et al (2019) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US preventive services task force. JAMA 322:666\u2013685","journal-title":"JAMA"},{"key":"797_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10549-020-05642-1","volume":"181","author":"IM Obdeijn","year":"2020","unstructured":"Obdeijn\u00a0IM, Mann\u00a0RM, Loo\u00a0CCE et\u00a0al (2020) The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers. Breast Cancer Res Treat 181:581\u2013588","journal-title":"Breast Cancer Res Treat"},{"key":"797_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40064-015-0793-1","volume":"4","author":"E Othman","year":"2015","unstructured":"Othman\u00a0E, Wang\u00a0J, Sprague\u00a0BL et\u00a0al (2015) Comparison of false positive rates for screening breast magnetic resonance imaging (MRI) in high risk women performed on stacked versus alternating schedules. SpringerPlus 4:77","journal-title":"SpringerPlus"},{"key":"797_CR16","volume-title":"European guidelines for quality assurance in breast cancer screening and diagnosis","author":"N Perry","year":"2006","unstructured":"Perry\u00a0N, Broeders\u00a0M, de Wolf\u00a0C et\u00a0al (2006) European guidelines for quality assurance in breast cancer screening and diagnosis. Office for Official Publications of the European Communities, Luxembourg"},{"key":"797_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1200\/JCO.2014.56.6232","volume":"33","author":"XA Phi","year":"2015","unstructured":"Phi\u00a0XA, Houssami\u00a0N, Obdeijn\u00a0IM et al (2015) Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age \u3009\/= 50\u00a0years: evidence from an individual patient data meta-analysis. J\u00a0Clin Oncol 33:349\u2013356","journal-title":"J Clin Oncol"},{"key":"797_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/bjc.2016.32","volume":"114","author":"XA Phi","year":"2016","unstructured":"Phi\u00a0XA, Saadatmand\u00a0S, De Bock\u00a0GH et al (2016) Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis. Br J Cancer 114:631\u2013637","journal-title":"Br J Cancer"},{"key":"797_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00129-020-04572-9","volume":"53","author":"AS Quante","year":"2020","unstructured":"Quante\u00a0AS, Engel\u00a0C, Kiechle\u00a0M et al (2020) Umstrukturierung der Risikoberechnung f\u00fcr die intensivierte Fr\u00fcherkennung im Deutschen Konsortium f\u00fcr Brust- und Eierstockkrebs. Gyn\u00e4kologe 53:259\u2013264","journal-title":"Gyn\u00e4kologe"},{"key":"797_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/tbj.13257","volume":"25","author":"K Rhiem","year":"2019","unstructured":"Rhiem\u00a0K, B\u00fccker-Nott\u00a0H\u2011J, Hellmich\u00a0M et al (2019) Benchmarking of a\u00a0checklist for the identification of familial risk for breast and ovarian cancers in a\u00a0prospective cohort. Breast\u00a0J 25:455\u2013460","journal-title":"Breast J"},{"key":"797_CR21","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1200\/JCO.2014.56.8626","volume":"33","author":"CC Riedl","year":"2015","unstructured":"Riedl\u00a0CC, Luft\u00a0N, Bernhart\u00a0C et al (2015) Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J\u00a0Clin Oncol 33:1128\u20131135","journal-title":"J Clin Oncol"},{"key":"797_CR22","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/S1470-2045(19)30275-X","volume":"20","author":"S Saadatmand","year":"2019","unstructured":"Saadatmand\u00a0S, Geuzinge\u00a0HA, Rutgers\u00a0EJT et\u00a0al (2019) MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a\u00a0multicentre, randomised, controlled trial. Lancet Oncol 20:1136\u20131147","journal-title":"Lancet Oncol"},{"key":"797_CR23","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/ijc.29534","volume":"137","author":"S Saadatmand","year":"2015","unstructured":"Saadatmand\u00a0S, Obdeijn\u00a0IM, Rutgers\u00a0EJ et\u00a0al (2015) Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). Int J Cancer 137:1729\u20131738","journal-title":"Int J Cancer"},{"key":"797_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/RLI.0b013e3181f3fcdf","volume":"46","author":"F Sardanelli","year":"2011","unstructured":"Sardanelli\u00a0F, Podo\u00a0F, Santoro\u00a0F et al (2011) Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk Italian 1 study): final results. Invest Radiol 46:94\u2013105","journal-title":"Invest Radiol"},{"key":"797_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow\u00a0D, Boetes\u00a0C, Burke\u00a0W et\u00a0al (2007) American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75\u201389","journal-title":"CA Cancer J Clin"},{"key":"797_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-3-030-41207-4_16","volume-title":"Breast MRI for high-risk screening","author":"A Selamoglu","year":"2020","unstructured":"Selamoglu\u00a0A, Gilbert\u00a0FJ (2020) Guidelines and recommendations on high-risk breast cancer screening all over the world: agreements and differences in. In: Sardanelli\u00a0F, Podo\u00a0F (Hrsg) Breast MRI for high-risk screening. Springer, Cham, S 251\u2013267"},{"key":"797_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1148\/radiol.2017170458","volume":"286","author":"S Vreemann","year":"2018","unstructured":"Vreemann\u00a0S, Gubern-Merida\u00a0A, Schlooz-Vries\u00a0MS et al (2018) Influence of risk category and screening round on the performance of an MR imaging and mammography screening program in carriers of the BRCA mutation and other women at increased risk. Radiology 286:443\u2013451","journal-title":"Radiology"},{"key":"797_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/cancers10120477","volume":"10","author":"E Warner","year":"2018","unstructured":"Warner\u00a0E (2018) Screening BRCA1 and BRCA2 mutation carriers for breast cancer. Cancers (Basel) 10:477","journal-title":"Cancers (Basel)"},{"key":"797_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1524-4741.2010.01018.x","volume":"17","author":"E Warner","year":"2011","unstructured":"Warner\u00a0E, Causer\u00a0PA, Wong\u00a0JW et al (2011) Improvement in DCIS detection rates by MRI over time in a\u00a0high-risk breast screening study. Breast\u00a0J 17:9\u201317","journal-title":"Breast J"},{"key":"797_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","volume":"148","author":"E Warner","year":"2008","unstructured":"Warner\u00a0E, Messersmith\u00a0H, Causer\u00a0P et\u00a0al (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671\u2013679","journal-title":"Ann Intern Med"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-020-00797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00117-020-00797-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-020-00797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T13:14:03Z","timestamp":1612185243000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00117-020-00797-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1007\/s00117-020-00797-w","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"14 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Bick gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}